SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Edderd who wrote (5649)2/24/1998 9:35:00 PM
From: EyeDrMike  Read Replies (3) of 23519
 
Not missing the point at all. All drugs have some warning or contraindiction or potential side effect, even common aspirin.

And in the elderly population., these side effects are an even bigger consideration.

Doesn't it concern you that the initial trials with Viagra was with only 12 healthy males, while the MUSE study had over 1500 participants?

"The efficacy of MUSE was demonstrated in the largest prospective clinical study conducted in organic erectile dysfunction to date. At 58 U.S. sites, 1,511 patient couples were studied. These patient couples had a 48-month mean duration of erectile dysfunction (at least 3-month history of no erections without medical assistance) and a patient age of 61.6 years. 66% of patients successfully completed in-clinic titration and achieved an erection sufficient for intercourse. Not all patients beginning titration had a successful dose and some patients could not tolerate MUSE, primarily due to penile pain.1"

Mike
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News